FDA Revokes Approval of Sun Pharma Seizure Drug Because of Manufacturing Problems

The U.S. Food and Drug Administration has revoked an approval issued to Sun Pharma Advanced Research Company Ltd. for its anti-seizure drug, Elepsia XR, because of manufacturing quality problems at Sun Pharma's Halol plant in the western Indian state of Gujarat. [9/28/15]

Search